Avik Pharmaceutical Limited - Company Profile

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 1979.
1979 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Avik Pharmaceutical Limited

Avik Pharmaceutical Limited, a active public limited company, was established on 25 September 1979 in Mumbai, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U99999MH1979PLC021711. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹12.00 Cr and a paid-up capital of ₹10.88 Cr.

Formerly known as Avik Pharmaceuticals Limited, Avik Pharmaceuticals Private Limited. It upholds a compliant status. Employing 174 professional, Its leadership includes Raj Kamal Prasad Verma (Director), Anant Rajendralal Thakore (Managing Director), Sushil Kumar Kumra (Director). Past directors included Raj Kamal Prasad Verma, Babu Jaicob Edakklathur, Anant Rajendralal Thakore. It holds ₹25.43 Cr open charges and ₹19.02 Cr settled loans. Its latest AGM occurred on 11 September 2025, with the balance sheet filed on 31 March 2025. It is based at Arvind Chambers,Gauri Compound,188 Kurla Road, Ground Floor,Western Express Highway, An, Dheri (E), Mumbai, Maharashtra, 400069.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U99999MH1979PLC021711

  • Registration Number

    021711

  • Incorporation Date

    25 September 1979

  • Authorized Capital

    ₹12.00 Cr

  • Paid-Up Capital

    ₹10.88 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 12.00 Cr
  • Paid Up Capital ₹ 10.88 Cr
  • Company Age 46 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 25.43 Cr
  • Satisfied Charges ₹ 19.02 Cr
  • Revenue Growth **** 25.22%
  • Profit Growth **** 49.19%
  • Ebitda **** 28.50%
  • Net Worth 536.69%
  • Total Assets **** 15.80%
Company report

Avik Pharmaceutical Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Avik Pharmaceutical Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Avik Pharmaceutical Limited?
Current Directors
Name Designation Appointment Date Status
Raj Kamal Prasad Verma Director 16 Sep 2024 Current
Anant Rajendralal Thakore Managing Director 25 Sep 1979 Current
Sushil Kumar Kumra Director 16 Sep 2024 Current
Jeevan Lal Nagori Director 18 Nov 2013 Current
Neha Anant Thakore Whole-Time Director 04 Jan 2022 Current
Rajeshree Maruti Chougule Company Secretary 15 Nov 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 10 Sep 2025 Past
Pramod Abcsdd Director 14 Sep 2022 Past
Pramod Abcsdd Managing Director 27 Sep 2020 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Chief Financial Officer - Past
Pramod Abcsdd Director 16 Sep 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Avik Pharmaceutical.

Avik Pharmaceutical Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25.22% increase. The company also saw a substantial improvement in profitability, with a 49.19% increase in profit. The company's net worth Soared by an impressive increase of 536.69%.

Avik Pharmaceutical revenue growth over time
Avik Pharmaceutical profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 25.22%
*******
*******
*******
*******
Revenue from Operations
*******
 26.09%
*******
*******
*******
*******
Total Assets
*******
 15.80%
*******
*******
*******
*******
Profit or Loss
*******
 49.19%
*******
*******
*******
*******
Net Worth
*******
 536.69%
*******
*******
*******
*******
EBITDA
*******
 28.50%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Avik Pharmaceutical?

In 2023, Avik Pharmaceutical had a promoter holding of 50.00% and a public holding of 50.00%. The company had 1 Joint Venture. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹254,300,000.00

Satisfied Charges

₹190,221,000.00

Charges Breakdown by Lending Institutions
  • Yes Bank Limited : 25.43 Cr
Latest Charge Details
Date Lender Amount Status
04 Jun 2025 Yes Bank Limited ₹5.00 Cr Open
20 May 2015 Yes Bank Limited ₹20.43 Cr Open
21 Apr 1999 Indian Bank ₹12.39 Cr Satisfied
04 Mar 1998 Central Bank Of India ₹1.30 Cr Satisfied
28 Apr 1994 Indian Bank ₹2.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Avik Pharmaceutical?

Avik Pharmaceutical has a workforce of 174 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Avik Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avik Pharmaceutical's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Avik Pharmaceutical
Recent Activity within the Organization
  • Director Appointment

    The activity Sarita Loriknath Yadav was appointed as a Cfo was appointed as a Cfo on 12 Oct 2025 & has been associated with this company since 4 months 5 days . was completed.

  • Annual General Meeting

    Avik Pharmaceutical Limited last Annual general meeting of members was held on 11 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Charges

    A charge with Yes Bank Limited amounted to Rs. 5.00 Cr with Charge ID 101111400 was registered on 04 Jun 2025. was recorded as a recent event.

  • Balance Sheet

    Progress on Avik Pharmaceutical Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Director Appointment

    The activity Rajeshree Maruti Chougule was appointed as a Company Secretary was appointed as a Company Secretary on 19 Dec 2024 & has been associated with this company since 1 year 1 month . was completed.

  • Director Appointment

    Rajeshree Maruti Chougule was appointed as a Company Secretary was appointed as a Company Secretary on 15 Nov 2024 & has been associated with this company since 1 year 3 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Avik Pharmaceutical Limited?

The CIN of Avik Pharmaceutical Limited is U99999MH1979PLC021711.

Where is Avik Pharmaceutical Limited headquartered?

Avik Pharmaceutical Limited is headquartered at Arvind Chambers,Gauri Compound,188 Kurla Road, Ground Floor,Western Express Highway, An, Dheri (E), Mumbai, Maharashtra, 400069.

When was Avik Pharmaceutical Limited incorporated?

Avik Pharmaceutical Limited was incorporated on 25 September 1979.

Who are the current directors of Avik Pharmaceutical Limited?

The current directors of Avik Pharmaceutical Limited are

What is the primary industry of Avik Pharmaceutical Limited?

The primary industry of Avik Pharmaceutical Limited is Manufacturing.

Is Avik Pharmaceutical Limited a listed company?

Avik Pharmaceutical Limited is unlisted.

What is the capital structure of Avik Pharmaceutical Limited?

The authorized capital of Avik Pharmaceutical Limited is ₹12.00 Cr, and the paid-up capital is ₹10.88 Cr.

What is the compliance status of Avik Pharmaceutical Limited?

The compliance status of Avik Pharmaceutical Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available